Discover why State Street SPDR S&P Biotech ETF (XBI) is up 30% YTD, its unique high-beta structure, and key risks for biotech investors.

Key Insights Acuity's estimated fair value is US$355 based on 2 Stage Free Cash Flow to Equity Acuity's US$350 ...

The Labor Department will release its numbers on September hiring and unemployment next Thursday, a month and a half late, ...

There’s no contest going into the final stretch of the year among US equity factor ETFs. So-called high-beta stocks – shares ...

When it comes to investing, sometimes less is more. Following the 5% Diversification Rule helps you keep a more balanced ...

The U.S. stock market is likely to stay volatile due to inflation concerns. Policy uncertainty is also affecting market sentiment. Therefore, it’s important to remain invested or increase holdings in ...

Banks may be indirectly exposed to trade policy through lending and through the broader effects of trade on the economy. Analysis finds that exposure to recent trade shocks was concentrated in large ...

The lower the beta, the more stable the stock. They’re probably not going to sizzle in a bull market, but they also will give up less ground in a bear market.

Does the November share price for Kronos Worldwide, Inc. reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cas ...

Mha's estimated fair value is UK£1.22 based on Dividend Discount Model Mha's UK£1.42 share price indicates it is trading at ...

The Gordon model allows for the fact that the market might put a price on a stock that's different from what you might estimate using the equation above. A higher stock price than predicted implies a ...